Sucampo CEO Peter Greenleaf Appointed Chairman of the Board of Directors
December 15, 2015 16:15 ET
|
Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., Dec. 15, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that Peter Greenleaf, Chief Executive...
Sucampo Completes Acquisition of R-Tech Ueno
December 07, 2015 06:45 ET
|
Sucampo Pharmaceuticals Inc
Immediately Accretive to Revenue, Earnings and Operating Cash Flows
Delivers Greater Manufacturing and Supply Chain Control
Expands Sucampo's Product Pipeline
ROCKVILLE, Md., Dec. 7, 2015...
Sucampo Announces Webcast of Its Presentation at Piper Jaffray 27th Annual Healthcare Conference
November 25, 2015 06:30 ET
|
Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., Nov. 25, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate presentation at...
Sucampo Reports Third Quarter 2015 Financial Results and Provides Corporate Update
November 04, 2015 06:30 ET
|
Sucampo Pharmaceuticals Inc
AMITIZA Revenue Performance Drives Income Growth
R-Tech Ueno Tender Offer Achieved Threshold; Sucampo Closed on Debt Financing
Company Reiterates 2015 Earnings Guidance
Company to Host...
Sucampo Closes $250 Million Credit Facility
October 22, 2015 07:30 ET
|
Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., Oct. 22, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced the closing of a $250.0 million credit...
Sucampo Announces Third Quarter 2015 Earnings Call
October 21, 2015 06:30 ET
|
Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., Oct. 21, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced that it will host its third quarter 2015...
Sucampo Announces Results of Tender Offer for R-Tech Ueno
October 14, 2015 07:30 ET
|
Sucampo Pharmaceuticals Inc
Tender Achieves Threshold and Tender Offer Period Concludes
Acquisition Expected to Close This Quarter
BETHESDA, Md., Oct. 14, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo)...
Timothy P. Walbert Joins Sucampo's Board of Directors
October 13, 2015 06:45 ET
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., Oct. 13, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced that Timothy P. Walbert has joined Sucampo's...
Sucampo Launches Tender Offer to Acquire R-Tech Ueno
August 26, 2015 06:17 ET
|
Sucampo Pharmaceuticals Inc
Acquisition Expected to be Immediately Accretive
Advances Sucampo Strategy to Strengthen Financial Performance and Diversify Pipeline
Acquisition Expected to Close in Q4 2015
Company to Host...
Sucampo Reports Second Quarter 2015 Financial Results and Corporate Update
August 05, 2015 06:30 ET
|
Sucampo Pharmaceuticals Inc
Year-over-Year Earnings Growth of 495% and EPS Growth of 425%
Year-over-Year Revenue Growth of 45%
Company Increases 2015 Earnings Guidance
Company to Host Conference Call Today at 8:30 a.m....